Aminoleban Adverse Reactions

(Rarely: < 0.1%, infrequently: 0.1% - < 5% no specific designation: 5% of frequency unknown.)
Clinically significant adverse reactions: Hypoglycemia: Hypoglycemia may occur. If the patient develops hypoglycemia, glucose should be administered promptly by intravenous infusion. In addition, appropriate nutrition management is required in such patients.
Hyperammonemia: Hyperammonemia has been reported. If the patient develops persistent hyperammonemia during the administration of AMINOLEBAN, discontinue administration and take measures to eliminate other nitrogen sources.
Other adverse reactions: Hypersensitivity: Symptoms such as skin rash may occur rarely. In the event of skin rash, discontinue the administration and institute appropriate treatment.
Gastrointestinal: Symptoms such as nausea and vomiting may occur infrequently.
Cardiovascular: Symptoms such as chest discomfort and palpitation may occur infrequently.
Metabolic: The nitrogen content of this preparation may induce a transient increase in blood ammonia concentrations.
Large dose and rapid administration: Acidosis may occur when large doses are administered rapidly.
Others: Chills, fever, headache and vascular pain may infrequently occur.